Brief: Nicox’S Partner Fera Pharmaceuticals To Investigate Naproxcinod As Covid-19 Adjuvant Treatment

Nicox SA

11/12/2020 06:36

Dec 11 (Reuters) - NICOX SA  NCOX.PA :
    * REG-NICOX’S PARTNER FERA PHARMACEUTICALS TO INVESTIGATE
NAPROXCINOD AS POTENTIAL COVID-19 ADJUVANT TREATMENT
    * FERA PLANS TO INITIATE PRE-CLINICAL PROOF-OF-CONCEPT
STUDIES IN
MODELS OF COVID-19 INFECTION IN EARLY 2021
    * NICOX WILL GRANT TO FERA WARRANTS TO ACQUIRE 10,000 NICOX
SHARES

Source text for Eikon:  ID:nGNE4LFJcS 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))